Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gisslinger

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|March 25, 1989
Long-term interferon therapy for thrombocytosis in myeloproliferative diseasesH Gisslinger, H Ludwig, W Linkesch, et al.
The New England Journal of Medicine|June 14, 1990
Erythropoietin treatment of anemia associated with multiple myelomaH Ludwig, E Fritz, H Kotzmann, et al.
British Journal of Haematology|October 1, 1991
Interferon in essential thrombocythaemiaH Gisslinger, A Chott, W Scheithauer, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|August 10, 1999
Neurological function during long-term therapy with recombinant interferon alphaN Mayr, J Zeitlhofer, L Deecke, et al.
Annals of Hematology|August 31, 1999
Massive disseminated intravascular coagulation and hyperfibrinolysis in alveolar rhabdomyosarcoma: case report and review of the literatureM Fiegl, A Weltermann, R Stindl, et al.
American Journal of Clinical Pathology|July 9, 1999
Clonality analysis using X-chromosome inactivation at the human androgen receptor gene (Humara). Evaluation of large cohorts of patients with chronic myeloproliferative diseases, secondary neutrophilia, and reactive thrombocytosisG Mitterbauer, K Winkler, H Gisslinger, et al.
British Journal of Haematology|July 1, 1993
Immunophenotypic characterization of myelomonocytic cells in patients with myelodysplastic syndromeT Felzmann, H Gisslinger, O Krieger, et al.
European Journal of Haematology|January 26, 1999
The effect of interferon alpha on myeloproliferation and vascular complications in polycythemia veraN Heis, C Rintelen, B Gisslinger, et al.
Prostaglandins|October 1, 1990
Impaired conversion of exogenous arachidonic acid by platelets to thromboxane B2 and correction of that deficiency by interferon-alphaH Sinzinger, W Linkesch, H Ludwig, et al.
Wiener Klinische Wochenschrift|November 4, 1988
[Defects in the prostaglandin system. VIII. A pathologic thrombocyte population in myeloproliferative syndrome, which forms no thromboxane from exogenous arachidonic acid]H Sinzinger, H Gisslinger, W Linkesch, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|March 25, 1989
Long-term interferon therapy for thrombocytosis in myeloproliferative diseasesH Gisslinger, H Ludwig, W Linkesch, et al.
The New England Journal of Medicine|June 14, 1990
Erythropoietin treatment of anemia associated with multiple myelomaH Ludwig, E Fritz, H Kotzmann, et al.
British Journal of Haematology|October 1, 1991
Interferon in essential thrombocythaemiaH Gisslinger, A Chott, W Scheithauer, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|August 10, 1999
Neurological function during long-term therapy with recombinant interferon alphaN Mayr, J Zeitlhofer, L Deecke, et al.
Annals of Hematology|August 31, 1999
Massive disseminated intravascular coagulation and hyperfibrinolysis in alveolar rhabdomyosarcoma: case report and review of the literatureM Fiegl, A Weltermann, R Stindl, et al.
American Journal of Clinical Pathology|July 9, 1999
Clonality analysis using X-chromosome inactivation at the human androgen receptor gene (Humara). Evaluation of large cohorts of patients with chronic myeloproliferative diseases, secondary neutrophilia, and reactive thrombocytosisG Mitterbauer, K Winkler, H Gisslinger, et al.
British Journal of Haematology|July 1, 1993
Immunophenotypic characterization of myelomonocytic cells in patients with myelodysplastic syndromeT Felzmann, H Gisslinger, O Krieger, et al.
European Journal of Haematology|January 26, 1999
The effect of interferon alpha on myeloproliferation and vascular complications in polycythemia veraN Heis, C Rintelen, B Gisslinger, et al.
Prostaglandins|October 1, 1990
Impaired conversion of exogenous arachidonic acid by platelets to thromboxane B2 and correction of that deficiency by interferon-alphaH Sinzinger, W Linkesch, H Ludwig, et al.
Wiener Klinische Wochenschrift|November 4, 1988
[Defects in the prostaglandin system. VIII. A pathologic thrombocyte population in myeloproliferative syndrome, which forms no thromboxane from exogenous arachidonic acid]H Sinzinger, H Gisslinger, W Linkesch, et al.
Pageof 10